Cargando…
PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429125/ http://dx.doi.org/10.1097/01.HS9.0000850876.64075.46 |
| _version_ | 1784779338491625472 |
|---|---|
| author | Li, Y. He, J. Han, X. Zheng, G. Zhang, E. Chen, Q. Yang, Y. He, D. Zhao, Y. Fu, J. Shou, L. Jiang, W. Jiang, W. Qian, S. Hu, H. He, H. Cai, Z. |
| author_facet | Li, Y. He, J. Han, X. Zheng, G. Zhang, E. Chen, Q. Yang, Y. He, D. Zhao, Y. Fu, J. Shou, L. Jiang, W. Jiang, W. Qian, S. Hu, H. He, H. Cai, Z. |
| author_sort | Li, Y. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429125 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94291252022-08-31 PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL Li, Y. He, J. Han, X. Zheng, G. Zhang, E. Chen, Q. Yang, Y. He, D. Zhao, Y. Fu, J. Shou, L. Jiang, W. Jiang, W. Qian, S. Hu, H. He, H. Cai, Z. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429125/ http://dx.doi.org/10.1097/01.HS9.0000850876.64075.46 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Li, Y. He, J. Han, X. Zheng, G. Zhang, E. Chen, Q. Yang, Y. He, D. Zhao, Y. Fu, J. Shou, L. Jiang, W. Jiang, W. Qian, S. Hu, H. He, H. Cai, Z. PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL |
| title | PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL |
| title_full | PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL |
| title_fullStr | PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL |
| title_full_unstemmed | PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL |
| title_short | PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL |
| title_sort | pb2011: chidamide combined with thalidomide, cyclophosphamide and dexamethasone (tc2d) as an oral quadruplet regimen for relapsed/refractory myeloma patients: initial results of a phase iia, multicenter trial |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429125/ http://dx.doi.org/10.1097/01.HS9.0000850876.64075.46 |
| work_keys_str_mv | AT liy pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT hej pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT hanx pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT zhengg pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT zhange pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT chenq pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT yangy pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT hed pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT zhaoy pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT fuj pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT shoul pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT jiangw pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT jiangw pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT qians pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT huh pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT heh pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial AT caiz pb2011chidamidecombinedwiththalidomidecyclophosphamideanddexamethasonetc2dasanoralquadrupletregimenforrelapsedrefractorymyelomapatientsinitialresultsofaphaseiiamulticentertrial |